A hybrid molecule that prohibits amyloid fibrils and alleviates neuronal toxicity induced by β-amyloid (1-42)

Biochemical and Biophysical Research Communications

Volumn 328, Issue 4, 2005, Pages 816-823

  Lee, Kyung Hyun ^a,b   Shin, Byung Hee ^b   Shin, Kye Jung ^b   Kim, Dong Jin ^b   Yu, Jaehoon ^a  

^a Seoul National University   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

Author keywords

Inhibitor for toxic amyloid peptide; Synthesis of styryl benzene ferulic acid hybrid molecules

Indexed keywords

1,3 BIS(2',4' DIMETHOXYSTYRYL)BENZENE; 1,3 BIS(3' METHOXY 4' HYDROXYSTYRYL)BENZENE; 1,3 BIS(3',4' DIMETHOXYSTYRYL)BENZENE; AMYLOID BETA PROTEIN[1-42]; BENZENE DERIVATIVE; FERULIC ACID; NOOTROPIC AGENT; THIOFLAVINE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CELL ASSAY; CONTROLLED STUDY; ELECTRON MICROSCOPY; FLUORESCENCE; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NEUROTOXICITY; PRIORITY JOURNAL; SURFACE PLASMON RESONANCE;

EID: 13744252140     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.01.030     Document Type: Article

References (26)

1. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356
2. D.I. Domingues, and B.D. Stooper Novel therapeutic strategies provide the real test for the amyloid hypothesis of Alzheimer's disease Trends Pharmacol. Sci. 23 2002 324 330
3. C.J. Barrow Advances in the development of Abeta-related therapeutic strategies for Alzheimer's disease Drug News Perspect. 15 2002 102 109
4. D.M. Walsh, I. Klyubin, J.V. Fadeeva, W.K. Cullen, R. Anwyl, M.S. Wolfe, M.J. Rowan, and D.J. Selkoe Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo Nature 416 2002 535 539
5. Y. Gong, L. Chang, K.L. Viola, P.L. Lacor, M.P. Lambert, C.E. Finch, G.A. Krafft, and W.L. Klein Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss Proc. Natl. Acad. Sci. USA 100 2003 10417 10422
6. M.D. Kirkitadze, G. Bitan, and D.B. Teplow Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies J. Neurosci. Res. 69 2002 567 577
7. I. Sanchez, C. Mahlke, and J. Yuan Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders Nature 421 2003 373 379
8. P. Hammarstrom, R.L. Wiseman, E.T. Powers, and J.W. Kelly Prevention of transthyretin amyloid disease by changing protein misfolding energetics Science 299 2003 713 716
9. G. Bitan, A. Lomakin, and D.B. Teplow Amyloid beta-protein oligomerization: prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins J. Biol. Chem. 276 2001 35176 35184
10. G. Bitan, M.D. Kirkitadze, A. Lomakin, S.S. Vollers, G.B. Benedek, and D.B. Teplow Amyloid beta-protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways Proc. Natl. Acad. Sci. USA 100 2003 330 335
11. Z.P. Zhuang, M.P. Kung, C. Hou, D. Skovronsky, T.L. Gur, K. Plossl, J.Q. Trojanowski, V.M. Lee, and H.F. Kung Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates J. Med. Chem. 44 2001 1905 1914
12. V.M. Lee Amyloid binding ligands as Alzheimer's disease therapies Neurobiol. Aging 23 2002 1039 1042
13. J.J. Yan, J.Y. Cho, H.S. Kim, K.L. Kim, J.S. Jung, S.O. Huh, H.W. Suh, Y.H. Kim, and D.K. Song Protection against beta-amyloid peptide toxicity in vivo with long-term administration of ferulic acid Br. J. Pharmacol. 133 2001 89 96
14. D. Martin, M. Salinas, R. Lopez-Valdaliso, E. Serrano, M. Recuero, and A. Cuadrado Effect of the Alzheimer amyloid fragment Abeta(25-35) on Akt/PKB kinase and survival of PC12 cells J. Neurochem. 78 2001 1000 1008
15. Z. Datki, A. Juhasz, M. Galfi, K. Soos, R. Papp, D. Zadori, and B. Penke Method for measuring neurotoxicity of aggregating polypeptides with the MTT assay on differentiated neuroblastoma cells Brain Res. Bull. 62 2003 223 229
16. H. LeVine III 4,4(′)-Dianilino-1,1(′)-binaphthyl-5,5(′) -disulfonate: report on non-beta-sheet conformers of Alzheimer's peptide beta (1-40) Arch. Biochem. Biophys. 404 2002 106 115
17. J.R. Harris In vitro fibrillogenesis of the amyloid beta 1-42 peptide: cholesterol potentiation and aspirin inhibition Micron 33 2002 609 626
18. C.W. Cairo, A. Strzelec, R.M. Murphy, and L.L. Kiessling Affinity-based inhibition of beta-amyloid toxicity Biochemistry 41 2002 8620 8629
19. H.C. Song, W.M. Li, G.R. Liu, and Z.L. Xu Study on the optical properties of 4,4′-bis-(2-(substituted-styryl))biphenyl and 1,4-bis-(2-(substituted- styryl))benzene Spectrochim. Acta A Mol. Biomol. Spectrosc. 59 2003 2041 2048
20. H.F. Kung, C.W. Lee, Z.P. Zhuang, M.P. Kung, C. Hou, and K. Plossl Novel stilbenes as probes for amyloid plaques J. Am. Chem. Soc. 123 2001 12740 12741
21. S.L. McGovern, E. Caselli, N. Grigorieff, and B.K. Shoichet A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening J. Med. Chem. 45 2002 1712 1722
22. H.A. Lashuel, D.M. Hartley, B.M. Petre, J.S. Wall, M.N. Simon, T. Walz, and P.T. Lansbury Jr. Mixtures of wild-type and a pathogenic (E22G) for of Aβ40 in vitro accumulate protofibrils, including amyloid pores J. Mol. Biol. 332 2003 795 808
23. S.Y. Lin, H.L. Chu, and Y.S. Wei Secondary conformations and temperature effect on structural transformation of amyloid beta (1-28), (1-40) and (1-42) peptides J. Biomol. Struct. Dyn. 20 2003 595 601
24. L.K. Simmons, P.C. May, K.J. Tomaselli, R.E. Rydel, K.S. Fuson, E.F. Brigham, S. Wright, I. Lieberburg, G.W. Becker, and D.N. Brems Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro Mol. Pharmacol. 45 1994 373 379
25. 1-42 aggregation and toxicity Biochem. Biophys. Res. Commun. 324 2004 64 69
26. H.A. Lashuel, D.M. Hartley, D. Balakhaneh, A. Aggarwal, S. Teichberg, and D.J.E. Callaway New class of inhibitors of amyloid-β fibril formation J. Biol. Chem. 277 2002 42881 42890